Breaking Barriers: Arts Lawyer Michael Quinn Takes on Purdue Pharma and the Sackler Family in High-Stakes Legal Battle

New York, NY – Becoming a specialist in a niche area of the law is often promoted as the most effective path for attorneys, but taking a more dynamic approach to a legal career can also be beneficial. Attorneys who are willing to learn and develop new areas of expertise may better serve clients whose needs extend across multiple areas of the law. This flexibility can be essential in certain situations. Michael Quinn, an arts lawyer at Eisenberg & Baum, LLP, discussed his experience representing clients in the fight against the Sackler Family and Purdue … Read more

Former Nuclear Engineering Professor’s Discrimination Lawsuit Ends with Purdue University Clear of Involvement, Jury Decides

HAMMOND, Indiana – A recent jury verdict in a discrimination case involving Purdue University highlights the complex nature of tenure decisions and allegations of bias. The case centered around former nuclear engineering professor Tatyana Sizyuk, who filed a lawsuit against Purdue and fellow professor Mamoru Ishii, claiming that she was discriminated against on the basis of her gender and non-Asian background. While the jury found that Ishii harbored discriminatory animus against Sizyuk, they concluded that Purdue University was not involved in the discrimination. During the trial, Sizyuk’s lawyer argued that Ishii’s discriminatory comments and influence … Read more

Purdue Pharma Bankruptcy Case: Supreme Court to Decide on Nondebtor Releases, Shaping Future of Chapter 11 Practice

Indianapolis, Indiana: The US Supreme Court is set to hear arguments in December in a case involving Purdue Pharma, the pharmaceutical company accused of contributing to the opioid epidemic. The central issue at stake is whether the Bankruptcy Code permits a Chapter 11 plan to provide releases to nondebtor third parties without their consent. This case has garnered significant attention from the public and bankruptcy professionals alike, as it has the potential to bring about significant changes in Chapter 11 bankruptcy practice. Purdue Pharma and its affiliates filed for Chapter 11 bankruptcy in the Bankruptcy … Read more

Exploring the Rise of Bankruptcy Court in Public Harms Litigation: Case in Focus – Harrington v. Purdue Pharma

Washington, DC – The Supreme Court will hear oral arguments on Monday in a case that highlights the increasing use of bankruptcy court by corporations involved in public harms litigation. The case in question is Purdue Pharma’s bankruptcy deal, which seeks to shield the company’s owners, the Sackler family, from civil liability in exchange for a $6 billion contribution to a settlement. This raises important questions about the role of bankruptcy court in addressing public health crises and whether bypassing the traditional civil litigation process is an effective solution. Bankruptcy court has become an attractive … Read more